Company Overview of Lipella Pharmaceuticals, Inc.
Lipella Pharmaceuticals, Inc., a development-stage biotechnology company, focuses on the development and commercialization of topical liposomal formulations for interstitial cystitis, hemorrhagic cystitis, and overactive bladder therapeutic applications. The company is engaged in developing novel products, which focus on trans-mucosal therapy by delivering local treatments directly to their site of action. It focuses on various therapeutic areas, such as urology, including interstitial cystitis, overactive bladder, hemorrhagic cystitis, and bladder cancer; gastroenterology, including eosinophilic esophagitis; ear, nose, and throat, including chronic rhinitis; and dermatology. The company was...
400 North Lexington Avenue LL103
Pittsburgh, PA 15208
Founded in 2005
Key Executives for Lipella Pharmaceuticals, Inc.
Co-Founder, Chairman of The Board, Chief Executive Officer and President
Chief Medical Officer, Executive Vice President and Director
Compensation as of Fiscal Year 2015.
Lipella Pharmaceuticals, Inc. Key Developments
Lipella Pharmaceuticals, Inc. Presents at BIO International Convention 2015, Jun-16-2015 10:45 AM
Jun 11 15
Lipella Pharmaceuticals, Inc. Presents at BIO International Convention 2015, Jun-16-2015 10:45 AM. Venue: Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States. Speakers: Michael B. Chancellor, Chief Medical Officer, Executive Vice President and Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries